Consumption of psychotropic medicines at a referral hospital in Namibia:

dc.contributor.authorKafula, Maria N.
dc.contributor.authorUgburo, Emmanuel
dc.contributor.authorKibuule, Dan
dc.date.accessioned2023-08-23T12:49:41Z
dc.date.available2023-08-23T12:49:41Z
dc.date.issued2020
dc.descriptionResearch article
dc.description.abstractSetting: In Namibia, the burden of mental illnesses is estimated at 25.6% and is expected to double by 2025. Few studies in sub-Saharan Africa estimate the consumption rates of psychotropic medicines as a proxy of irrational use. Aim: The consumption rate of psychotropic medicines at a referral hospital was determined. Method: A hospital-based retrospective medicine utilization analysis of Facility Electronic Stock Card (FESC) psychotropic medication was conducted at Intermediate Hospital Katutura over a 7 year period, 2011-2017. Data on consumption and expenditure on psychotropic medicines were abstracted from FESC and analysed using descriptive statistics in SPSS v22. The main outcomes were consumption rates, daily Defined Dose, (DDD) and/or expenditure. Results: Of the 580 351,4 DDD of psychotropic medicines consumed, 84% were anti-psychotics, 9.2% anti-depressants and 6.8% anxiolytics. Anti-psychotics (48.8%) and anxiolytics (47.9%) had the highest consumption by cost relative to antidepressants (3.3%). The most consumed antidepressants were imipramine (62%) by DDD and fluoxetine (55.8%) by cost. The most consumed anti-psychotics were chlorpromazine (74.6%) by DDD and haloperidol (68.4%) by cost respectively. Diazepam (79.4%) and hydroxyzine (94.2%) were most consumed sedative-hypnotics by DDD and cost respectively. Conclusion: The consumption of new psychotropics contributes to higher costs. There is need for cost-effectiveness analysis of new versus conventional psychotropics to optimize treatment, outcomes and costs. Keywords: Pyschotropics, consumption rate, DDD, Namibia.
dc.description.sponsorshipUniversity of Namibia, Intermediate Katutura Hospital, Busitema University
dc.identifier.citationKafula MN, Ugburo E, Kibuule D. Consumption of psychotropic medicines at a referral hospital Namibia: findings and implications. Afri Health Sci. 2020; 20(2): 1000-1010. https://doi.org/10.4314/ahs.v20i2.57
dc.identifier.urihttps://doi.org/10.60682/wknt-np02
dc.language.isoen
dc.relation.ispartofseriesAfrican Health Sciences; Vol. 20 No. 2 (2020)
dc.subjectResearch Subject Categories::MEDICINE::Physiology and pharmacology::Pharmacological research::Pharmacology
dc.titleConsumption of psychotropic medicines at a referral hospital in Namibia:
dc.title.alternativefindings and implications
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Kafula,-M.,-Ugburo,-E.-&-Kibuule,-D._Dept._of_Clinical_Pharmacology_2020.pdf
Size:
284.21 KB
Format:
Adobe Portable Document Format
Description:
Research article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: